글로벌 심방세동 시장 - 산업 동향 및 2030년까지의 예측

심방세동 시장 분석 및 규모

심방 세동은 특히 노인 인구에서 흔한 심장 부정맥입니다. 전 세계 인구가 고령화됨에 따라 심방 세동 사례의 유병률이 높아져 진단, 치료 및 관리 옵션에 대한 수요가 증가하고 있습니다. 심전도(ECG), 심장 초음파 및 기타 진단 도구 의 기술적 발전으로 심방 세동 진단의 정확도와 효율성이 향상되었습니다. 조기에 정확한 진단을 통해 시기적절한 치료가 가능해져 시장 성장이 촉진됩니다. 제약 회사와 의료 기기 제조업체는 심방 세동에 대한 새로운 치료 옵션과 요법을 지속적으로 개발하고 있습니다. 이러한 혁신에는 약물, 카테터 절제술 및 심장 박동 조절기 및 이식형 심장 제세동기(ICD) 와 같은 이식형 장치가 포함됩니다 .

Data Bridge Market Research는 2022년에 14,530.00백만 달러였던 글로벌 심방 세동 시장이 2030년까지 36,233.52백만 달러에 도달할 것으로 예상하고, 2023년에서 2030년까지의 예측 기간 동안 12.1%의 CAGR을 보일 것으로 분석했습니다. "전형적인 심방 세동"은 의료 분야에 대한 투자 증가로 인해 글로벌 심방 세동 시장의 유형 세그먼트를 지배하고 있습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

심방세동 시장 범위 및 세분화

시장 정의

심방 세동은 심방(심장의 위쪽 챔버)에 영향을 미치는 심장 부정맥(비정상적인 심장 리듬)의 한 유형입니다. 심방에서 빠르고 규칙적인 전기적 활동이 특징이며, 심실(심장의 아래쪽 챔버)보다 더 빠른 속도로 뛰게 합니다. 이로 인해 혈액의 펌핑이 비효율적으로 이루어져 심계항진, 호흡 곤란, 현기증, 피로와 같은 증상이 나타날 수 있습니다. 심방 세동은 심각한 의학적 상태로 간주되며 치료가 필요할 수 있으며, 여기에는 심박수나 리듬을 조절하는 약물, 전기적 심장 전환 또는 절제와 같은 카테터 기반 시술이 포함될 수 있습니다.

"글로벌 심방 조동 시장"이라는 용어는 전 세계적으로 심방 조동의 진단, 치료 및 관리와 관련된 제품 및 서비스 시장을 말합니다. 이 시장은 심방 조동이 있는 환자의 치료에 기여하는 다양한 의료 분야와 산업을 포함합니다.

글로벌 심방세동 시장 역학

운전자

• 심방세동의 증가 추세

Atrial flutter is a common cardiac arrhythmia, especially among the elderly population. With the global aging population and the rise in risk factors such as obesity and hypertension, there may be a higher prevalence of atrial flutter cases, driving the demand for treatments and management options.

• Rising Government Initiatives

Government policies and initiatives aimed at improving cardiac care and reducing the burden of cardiovascular diseases can stimulate market growth. This may include funding for research, awareness campaigns, and improved healthcare infrastructure.

Opportunities

• Advancements in Medical Technology

The development of new medical devices, drugs, and treatment options for atrial flutter can expand the global market. Innovations in cardiac rhythm management devices, ablation techniques, and pharmaceuticals can improve patient outcomes and reduce the burden of the disease.

• Collaboration and Mergers

Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, rising number of market players will further expand the market's growth rate in the future. 

Restraints/Challenges

• Regulatory Hurdles

Regulatory approvals for new medical devices and pharmaceuticals can be a lengthy and costly process. Companies operating in this market may face challenges in getting their products approved for use.

• High Cost associated in Manufacturing

On the other hand, the high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.

This global atrial flutter market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global atrial flutter market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• On March 2023, the University of California, San Francisco announced a study of clinical trials for Baylis Versacross RF wire. This study is a randomized controlled trial that investigates the comparative effectiveness of Baylis's Versacross RF wire and the conventional Baylis RF needle in puncturing through a thin wall in the heart, known as "transseptal puncture," during cardiac ablation procedures. The primary outcome measure is the time taken to achieve a successful transseptal puncture
• On March 2023, R-Pharm announced a study of clinical trials for Refralon. The objective of this retrospective registry is to assess the effectiveness and safety of Refralon, a concentrated solution for intravenous injection, for chemical cardioversion in routine clinical practice among patients with paroxysmal and persistent atrial fibrillation and flutter
• On April 2023, NeuTrace Inc announced a study of clinical trials for Electroanatomic mapping with the NeuTrace System. The trial aims to assess physician acceptance of the NeuTrace System v1.0 for cardiac electroanatomic mapping through a prospective, non-randomized, single-arm feasibility trial

Global Atrial Flutter Market Scope

The global atrial flutter market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Typical Atrial Flutter
• Atypical Atrial Flutter
• Left Atrial Flutter
• Reverse Typical Atrial Flutter
• Incisional Atrial Re-entry

Treatment

• Antiarrhythmics
• Beta-blockers
• Anticoagulants
• Cardioversion
• Catheter ablation
• Surgery
• Others

Diagnosis

• Holter monitoring
• Blood Tests
• Electrocardiography (ECG)
• Event monitoring
• Others

Dosage

• Tablet
• Injection
• Others

Route of Administration

• Oral
• Intravenous
• Others

Symptoms

• Fatigue
• Chest Pain
• Shortness of Breath
• Palpitations
• Pre-Syncope
• Blurry Vision
• Light Headedness
• Others

End Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Atrial Flutter Market Regional Analysis/Insights

Global atrial flutter market is analyzed, and market size insights and trends are provided by type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the global atrial flutter market  report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

North America dominates the global atrial flutter market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030. This is due to the presence of FDA approved wound debridement devices and rising healthcare expenditure will further propel the market's growth rate in this region. In addition, favourable health remuneration policies, rise in chronic wounds, and a growing elderly population will further propel the market's growth rate in this region.

Asia-Pacific is expected to be the fastest growing region in the global atrial flutter market during the forecast period of 2022-2029 due to increase in the number of insurance payers in this region. Also, the development of private healthcare sector and rising awareness among the people will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global atrial flutter market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global atrial flutter market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global atrial flutter market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Atrial Flutter Market Share Analysis

The global atrial flutter market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global atrial flutter market.

Some of the major players operating in the global atrial flutter market are:

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• Boehringer Ingelheim International GmbH. (Germany)
• Bristol-Myers Squibb Company (U.S.)
• Abbott (U.S.)
• Sanofi (France)
• Novartis AG (Switzeland)
• Merck Sharp & Dohme Corp. (U.S.)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• 엘리 릴리 앤드 컴퍼니(미국)
• 아스트라제네카(영국)
• Bayer AG(독일)
• Teva Pharmaceutical Industries Ltd. (영국)
• Baxter(독일)
• Aspen Holdings(남아프리카 공화국)
• 다이이치 산쿄 주식회사(일본)
• 제넨텍 주식회사(미국)
• 루팡(인도)
• 마일런 NV(미국)
• Sun Pharmaceutical Industries Ltd. (인도)
• Amneal Pharmaceuticals LLC. (미국)

SKU-66783